Company Overview

Development Stage

About the Company

[Summary] Providing solutions for personalized treatment and health management

WuXi AppTec (stock code: 603259.SH/2359.HK) is a leading open-access capability and technology platform company. It provides comprehensive, integrated laboratory research and manufacturing services for the global pharmaceutical and medical device industries, from drug discovery and development to market commercialization. Adhering to a research-first and client-centric mission, WuXi AppTec helps global clients shorten drug and medical device development cycles and reduce R&D costs through its high cost-performance ratio and efficient service platforms. Its platform encompasses chemical drug R&D and manufacturing, cell and gene therapy R&D and manufacturing, drug R&D and medical device testing, and is currently supporting thousands of R&D innovation projects for over 3,500 innovation partners from more than 30 countries worldwide. It is committed to bringing the latest and best medical and health products to patients globally, realizing the dream of 'making drugs and treating diseases accessible to everyone.'

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (112 open positions)

Manage
Note: How fast is hiring at Suzhou WuXi AppTec New Drug Development Co., Ltd. growing? 2026: 125 openings (up 37%), 2025: 91 openings (up 2175%), 2024: 4 openings (down 91%), 2023: 45 openings (down 29%), 2022: 63 openings (down 62%), 2021: 167 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 1600%
  • 2024: Down 92%
  • 2023: Down 29%
  • 2022: Flat 0%-
Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Suzhou WuXi AppTec New Drug Development Co., Ltd. growing? Master's recruitment over the years: 2025: 17 openings (up 1600%), 2024: 1 openings (down 92%), 2023: 12 openings (down 29%), 2022: 17 openings (flat), 2021: 17 openings.

Doctoral Degree Job Demand Analysis

(More)
-35%
Growth Rate
2026 vs 2025
Doctoral Hiring by Year: 2026 — 9 fewer jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Suzhou WuXi AppTec New Drug Development Co., Ltd. growing? Doctorate recruitment over the years: 2026: 17 openings (up 247%), 2025: 26 openings (up 1600%), 2023: 12 openings (down 29%), 2022: 8 openings (flat), 2021: 12 openings.

R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Suzhou WuXi AppTec New Drug Development Co., Ltd.? Based on an analysis of 's job postings over the past year, "生物/制药/化工/环保类" demand: 46.3%, "科研类": 31.3%, "其他(研发和技术类)": 27.6%, "医疗卫生/美容保健类": 22.4%, "计算机/网络/技术类": 9.9%, "机械/仪器仪表类": 5.9%. For reference only.

— What Are the Salaries Like? (272 records)

Manage
salary range: 6K - 50K, 56.3% of roles pay ¥10-30K
Note: salary statistics are based on 272 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Suzhou WuXi AppTec New Drug Development Co., Ltd.?56.3% of positions earn 10-30K, Fresh graduate salary: ¥25.0K。生物/制药/化工/环保类 average salary ¥18.7K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at Suzhou WuXi AppTec New Drug Development Co., Ltd.? We provide: 研究员,dm,专题负责人,分析,td,vb,md,vp,sd,ie,ir,cto,临床,医疗器械,运营,项目经理,化学,管培生,运维,采购. Click to view detailed salary analysis by job.

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Job Category

  • 生物/制药/化工/环保类
    45.9% of total 45.9%
  • 科研类
    31% of total 31%
  • 其他(研发和技术类)
    27% of total 27%
  • 经营管理类
    24.9% of total 24.9%

Education

  • 本科
    42.3% of total 42.3%
  • 硕士
    26.7% of total 26.7%
  • 博士
    22.1% of total 22.1%
  • 大专
    8.9% of total 8.9%

Experience

  • 不限
    42.7% of total 42.7%
  • 1-3年
    34.9% of total 34.9%
  • 3-5年
    13.5% of total 13.5%
  • 5-10年
    8.5% of total 8.5%
View Detailed Analysis

What does Suzhou WuXi AppTec New Drug Development Co., Ltd. require? Who is Suzhou WuXi AppTec New Drug Development Co., Ltd. hiring? recruitment: 生物/制药/化工/环保类占比最多占45.9%,其次是科研类占31%. What education can get in at ? 本科占比最多占42.3%,其次是硕士占26.7%. High education required at ? 硕士占26.7%,博士占22.1%. Work experience required at ? 不限占比最多占42.7%,其次是1-3年占34.9%. Where are the job locations at ? 苏州占比最多占91.8%,其次是南京占8.2%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 105,000万(元)
Legal Representative: 张朝晖
Date Established:
Credit Code: 91320500793335379M
Registered Address: 苏州市吴中区吴中大道1318号

Partners & Suppliers

药明康德为辉瑞提供新药研发外包服务 Source
合作客户 制药公司
药明康德为百时美施贵宝提供药物开发服务 Source
合作客户 制药公司
药明康德为默沙东提供药物发现与临床前研究服务 Source
合作客户 制药公司
提供细胞治疗产品的生产服务 Source
合作客户 CDMO/研发服务
药明康德为基石药业提供临床前研发服务 Source
合作客户 生物技术公司

People who follow this company also follow

Competitors (Similar Companies)

“Making drugs and cures accessible to all”
“A leading open-access capability and technology platform company for p”
“To develop high-quality biologics that are accessible and affordable f”
“Accelerating global biologic drug R&D processes, reducing R&D costs, a”
“Research, development, and production of anti-tumor and surgical medic”
“Committed to the independent R&D, production, and sales of innovative ”
生命科学 生物信息 生物制药 干细胞
“Dedicated to the research and development of molecularly targeted drug”
“Continuously innovating to bring patients medicines that significantly”
“Helping partners successfully develop new drugs, reducing R&D costs an”
“Continuous innovation, safeguarding health”
医药 制药/药业 生物科技/生物工程 药物研发
“In the rapidly growing biopharmaceutical field, accelerate and transfo”
制药/药业 抗体 蛋白质工程 生物制药
“One of the first China Time-honored Brands”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates